IntelliPharmaCeutics International (IntelliPharmaCeutics International) Capex-to-Operating-Cash-Flow : 0.00 (As of Aug. 2023)

IntelliPharmaCeutics International Capex-to-Operating-Cash-Flow Chart

IntelliPharmaCeutics International Annual Data
	Trend	Nov13	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22
Capex-to-Operating-Cash-Flow		Get a 7-Day Free Trial					-	-	0.04	-	-

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Capex-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow

For the Biotechnology subindustry, IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow falls into.

IntelliPharmaCeutics International Capex-to-Operating-Cash-Flow Calculation

IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Nov. 2022 is calculated as

IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow for the quarter that ended in Aug. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IntelliPharmaCeutics International  (OTCPK:IPCIF) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

IntelliPharmaCeutics International Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description